Roivant Sciences Ltd (ROIV) insider trading
Every open-market stock purchase and sale by Roivant Sciences Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Mayukh Sukhatme (C-suite exec) and 3 others sold $59.8M in the last 90 days.
- Last insider buy: Matthew Gline (CEO), $50K, 13 months ago.
- Congress: Lisa McClain sold $1K to $15K, 12 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $878M (45 sales). Last close $36.80 on Oct 21, 2026.
Recent ROIV insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 16, 2026 | Matthew Gline (CEO) | Sold (not open market) | $1.2M |
| Oct 16, 2026 | Mayukh Sukhatme (C-suite exec) | Sold (not open market) | $670K |
| Oct 1, 2026 | Melissa B Epperly (Director) | Sold | $608K |
| Oct 1, 2026 | Melissa B Epperly (Director) | Sold | $32.9K |
| Oct 1, 2026 | Melissa B Epperly (Director) | Bought (not open market) | — |
| Sep 30, 2026 | Eric Venker (CEO) | Sold | $7.3M |
| Sep 30, 2026 | Matthew Gline (CEO) | Sold (not open market) | $2.8M |
| Sep 30, 2026 | Mayukh Sukhatme (C-suite exec) | Sold (not open market) | $1.7M |
| Sep 30, 2026 | Frank Torti (President) | Bought (not open market) | $1.5M |
| Sep 30, 2026 | Eric Venker (CEO) | Bought (not open market) | — |
| Sep 20, 2026 | Jennifer Humes (C-suite exec) | Sold (not open market) | $154K |
| Sep 20, 2026 | Richard Pulik (CFO) | Sold (not open market) | $84.7K |
| Sep 16, 2026 | Ilan Oren (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Melissa B Epperly (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Melissa B Epperly (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Daniel Allen Gold (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Daniel Allen Gold (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Ilan Oren (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Meghan Fitzgerald (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Meghan Fitzgerald (Director) | Bought (not open market) | — |
| Sep 16, 2026 | James C Momtazee (Director) | Bought (not open market) | — |
| Sep 16, 2026 | James C Momtazee (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Keith S Manchester (Insider) | Bought (not open market) | — |
| Sep 16, 2026 | Keith S Manchester (Insider) | Bought (not open market) | — |
| Sep 15, 2026 | Meghan Fitzgerald (Director) | Sold | $187K |
Who's trading ROIV
- Mayukh Sukhatme, C-suite exec: sold $109M (13 sales), last Oct 16, 2026
- Matthew Gline, CEO: sold $46.2M (4 sales), last Oct 16, 2026
- Melissa B Epperly, Insider: sold $2.6M (7 sales), last Oct 1, 2026
- Eric Venker, CEO: sold $69.8M (15 sales), last Sep 30, 2026
- Frank Torti, President: sold $82M (3 sales), last Sep 30, 2026
- Jennifer Humes, C-suite exec: sold $384K (1 sale), last Sep 20, 2026
- Richard Pulik, CFO: sold $9.1M (2 sales), last Sep 20, 2026
- Daniel Allen Gold, Insider: sold $147M (19 sales), last Sep 16, 2026
- James C Momtazee, Insider: other filings, last Sep 16, 2026
- Ilan Oren, Insider: other filings, last Sep 16, 2026
- Meghan Fitzgerald, Insider: sold $3.3M (5 sales), last Sep 16, 2026
- Keith S Manchester, Insider: sold $154M (20 sales), last Sep 16, 2026
- QVT Financial LP, Insider: sold $147M (19 sales), last Jun 30, 2026
- Vivek Ramaswamy, 10% owner: sold $106M (6 sales), last Dec 15, 2025
- Lisa McClain, Representative: bought $8K (1 buy), sold $16K (2 sales), last Oct 31, 2025
Get free alerts when an insider at Roivant Sciences Ltd files a new trade →